LENTINI RENEE (V.P.-Fin., Prin. Acctg. Off.) sold 15.2% of their position (2.63K shares) of IMMUNOGEN, INC. on the open market
Open‑market sale worth $77.1K — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 2/6/2024ACC: 0001415889-24-002870
Officer· V.P.-Fin., Prin. Acctg. Off.
Since Jan 2021
-2.63K
Net shares
Net seller
$77.1K
Total sold
1
Open market trades
0B · 1S
3
Total transactions
8.44K acquired · 11.07K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+8.44K
Price / share
—
Trade value
—
% of position
94.6%
2/2/2024
8.92K→17.35K
Common Stock
Direct
Shares
−2.63K
Price / share
$29.30
Trade value
$77.09K
% of position
15.2%
2/5/2024
17.35K→14.72K
Total
Net shares
+5.80K
Net value
-$77.09K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/2/2024 | M · Option Exercise | +8.44K | — | — | 94.6% | 8.92K | 17.35K |
| Common Stock Direct | 2/5/2024 | S · Sale | −2.63K | $29.30 | $77.09K | 15.2% | 17.35K | 14.72K |
| Total | +5.80K | -$77.09K | ||||||
Derivative Transactions1
Restricted Stock Unit
Direct
Converts to
Common Stock
8.44K shares
Shares
−8.44K
Strike price
0
Held after
16.87K
Exercisable
—
2/2/2024
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Restricted Stock Unit Direct | Common Stock8.44K shares | 2/2/2024 | M · Option Exercise | −8.44K | 0 | — | 16.87K |